PubMed for id: 2476785343

Year	Number of Results
1995	2
1996	2
1997	1
1998	1
2020	1
2021	1
2022	2
2024	1

1

Evaluation of the genetic diversity of KIR genes in patients with endometrial cancer.

Shiravani Z, Mirshekari K, Larki MH, Shafiee N, Haghshenas MR, Ghaderi A, Fattahi MJ. Shiravani Z, et al. J Reprod Immunol. 2024 Mar;162:104217. doi: 10.1016/j.jri.2024.104217. Epub 2024 Feb 16. J Reprod Immunol. 2024. PMID: 38387251

2

KIR2DS2 Expression Identifies NK Cells With Enhanced Anticancer Activity.

Blunt MD, Vallejo Pulido A, Fisher JG, Graham LV, Doyle ADP, Fulton R, Carter MJ, Polak M, Johnson PWM, Cragg MS, Forconi F, Khakoo SI. Blunt MD, et al. J Immunol. 2022 Jul 15;209(2):379-390. doi: 10.4049/jimmunol.2101139. Epub 2022 Jun 29. J Immunol. 2022. PMID: 35768150 Free PMC article.

3

Killer Cell Immunoglobulin-Like Receptor Haplotype B Modulates Susceptibility to EBV-Associated Classic Hodgkin Lymphoma.

Jiang P, Nolte IM, Hepkema BG, Stulp M, van den Berg A, Diepstra A. Jiang P, et al. Front Immunol. 2022 Jan 27;13:829943. doi: 10.3389/fimmu.2022.829943. eCollection 2022. Front Immunol. 2022. PMID: 35154153 Free PMC article.

4

Clinical and histopathological changes in different KIR gene profiles in chronic HCV Romanian patients.

Ursu LD, Calenic B, Diculescu M, Dima A, Stoian IT, Constantinescu I. Ursu LD, et al. Int J Immunogenet. 2021 Feb;48(1):16-24. doi: 10.1111/iji.12515. Epub 2020 Sep 22. Int J Immunogenet. 2021. PMID: 32961633

5

The repertoire of HLA-Cw-specific NK cell receptors CD158 a/b (EB6 and GL183) in individuals with different HLA phenotypes.

Frohn C, Schlenke P, Kirchner H. Frohn C, et al. Immunology. 1997 Dec;92(4):567-70. doi: 10.1046/j.1365-2567.1997.00374.x. Immunology. 1997. PMID: 9497500 Free PMC article.

6

Immunoreceptor DAP12 bearing a tyrosine-based activation motif is involved in activating NK cells.

Lanier LL, Corliss BC, Wu J, Leong C, Phillips JH. Lanier LL, et al. Nature. 1998 Feb 12;391(6668):703-7. doi: 10.1038/35642. Nature. 1998. PMID: 9490415

7

Alternatively spliced forms of human killer inhibitory receptors.

Döhring C, Samaridis J, Colonna M. Döhring C, et al. Immunogenetics. 1996;44(3):227-30. doi: 10.1007/BF02602590. Immunogenetics. 1996. PMID: 8662091 No abstract available.

8

The human leukocyte antigen (HLA)-C-specific "activatory" or "inhibitory" natural killer cell receptors display highly homologous extracellular domains but differ in their transmembrane and intracytoplasmic portions.

Biassoni R, Cantoni C, Falco M, Verdiani S, Bottino C, Vitale M, Conte R, Poggi A, Moretta A, Moretta L. Biassoni R, et al. J Exp Med. 1996 Feb 1;183(2):645-50. doi: 10.1084/jem.183.2.645. J Exp Med. 1996. PMID: 8627176 Free PMC article.

9

Molecular clones of the p58 NK cell receptor reveal immunoglobulin-related molecules with diversity in both the extra- and intracellular domains.

Wagtmann N, Biassoni R, Cantoni C, Verdiani S, Malnati MS, Vitale M, Bottino C, Moretta L, Moretta A, Long EO. Wagtmann N, et al. Immunity. 1995 May;2(5):439-49. doi: 10.1016/1074-7613(95)90025-x. Immunity. 1995. PMID: 7749980 Free article.

10

Cloning of immunoglobulin-superfamily members associated with HLA-C and HLA-B recognition by human natural killer cells.

Colonna M, Samaridis J. Colonna M, et al. Science. 1995 Apr 21;268(5209):405-8. doi: 10.1126/science.7716543. Science. 1995. PMID: 7716543

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

10 results

Results by year